O-GlcNAc cycling: Implications for neurodegenerative disorders
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The dynamic post-translational modification of proteins by O-linked N-Acetylglucosamine (O-GlcNAc), termed O-GlcNAcylation, is an important mechanism for modulating cellular signaling pathways. O-GlcNAcylation impacts transcription, translation, organelle trafficking, proteasomal degradation and apoptosis. O-GlcNAcylation has been implicated in the etiology of several human diseases including type-2 diabetes and neurodegeneration. This review describes the pair of enzymes responsible for the cycling of this post-translational modification: O-GlcNAc transferase (OGT) and β-N-acetylglucosaminidase (OGA), with a focus on the function of their structural domains. We will also highlight the important processes and substrates regulated by these enzymes, with an emphasis on the role of O-GlcNAc as a nutrient sensor impacting insulin signaling and the cellular stress response. Finally, we will focus attention on the many ways by which O-GlcNAc cycling may affect the cellular machinery in the neuroendocrine and central nervous systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“Protein aggregation is one of the characteristic features of neurodegenerative disorders and in AD, aggregates of hyperphosphorylated βamyloid peptide and tau are a hallmark of this disease (Ross and Poirier, 2004).”
BackgroundLee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 1×
“This group of diseases includes AD, frontotemporal dementia with parkinsonism (FTDP-17), Pick’s disease and Amyotrophic lateral sclerosis (Lou Gehrig’s disease), reviewed in (Lee et al., 2001).”
BackgroundRegulation of aging and age-related disease by DAF-16 and heat-shock factor
Hsu, A.-L., Murphy, C. T., & Kenyon, C. (2003) · Science · doi:10.1126/science.1083701 · Cited by 1,513 · cited 1×
“Specifically, lowered insulin signaling correlated with enhanced longevity and a lowered burden of neurotoxicity (Morley et al., 2002; Hsu et al., 2003).”
BackgroundCycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Hart, G. W., Housley, M. P., & Slawson, C. (2007) · Nature · doi:10.1038/nature05815 · Cited by 1,418
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907 · cited 2×
“, 2006) and mOGT may be associated with activation of transcription factor Sp1 by mitochondrial superoxide overproduction (Du et al., 2001).”
BackgroundA potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.96 · Cited by 717 · cited 1×
“However, studies that increase O-GlcNAc using an OGA-specific inhibitor, in PC-12 cells and in a whole animal model, show a decrease in endogenous tau phosphorylation at several physiologically relevant sites (Yuzwa et al., 2008).”
BackgroundUntangling tau hyperphosphorylation in drug design for neurodegenerative diseases
Mazanetz, M. P., & Fischer, P. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2111 · Cited by 459 · cited 1×
“There are at least 30 known sites of phosphorylation on tau under physiological conditions (reviewed in Mazanetz and Fischer, 2007), thus making it improbable for O-GlcNAc to be regulating all of these sites.”
BackgroundThe Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine
Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361 · cited 2×
“…of the proteins known to be glycosylated by OGT include β-amyloid precursor protein (Griffith and Schmitz, 1995), microtubule associated proteins (Arnold et al., 1996; Ding and Vandre, 1996), synapsins (Cole and Hart, 1999), neurofilaments (Dong et al., 1996; Al-Chalabi and Miller, 2003),…”
BackgroundProteasomal degradation of tau protein
David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01137.x · Cited by 327 · cited 4×
“, 1989) and does not have an absolute requirement for ubiquitinylation (David et al., 2002).”
BackgroundInfluentialGlycan-dependent signaling: O-linked N-acetylglucosamine
HANOVER, J. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0094rev · Cited by 283
Self-citationJohnson, G. V. W., Jope, R. S., & Binder, L. I. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91150-9 · Cited by 161
Li, S. ‐., Liu, Y., Sigmon, V. K., McCort, A., & Ren, J. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00387.x · Cited by 95
Clathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain
Murphy, J. E., Hanover, J. A., Froehlich, M., DuBois, G., & Keen, J. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31968-3 · Cited by 54
Self-citation
Cited by
Mitochondrial Trafficking in Neurons
Schwarz, T. L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011304 · Cited by 525
“Both HUMMR, as a sensor of hypoxic stress, and OGT, as a likely sensor of metabolic state (Lazarus et al. 2009), may help mitochondria redistribute themselves in response to changing environmental and energetic conditions.”
Backgroundlinking metabolism to epigenetics through O-GlcNAcylation
Hanover, J. A., Krause, M. W., & Love, D. C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3334 · Cited by 414
Self-citationKhoushab, F., & Yamabhai, M. (2010) · Marine Drugs · doi:10.3390/md8071988 · Cited by 413
Wang, Z. V., Deng, Y., Gao, N., Pedrozo, Z., Li, D. L., Morales, C. R., Criollo, A., Luo, X., Tan, W., Jiang, N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.014 · Cited by 409
Ruan, H.-B., Han, X., Li, M.-D., Singh, J. P., Qian, K., Azarhoush, S., Zhao, L., Bennett, A. M., Samuel, V. T., Wu, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.006 · Cited by 296
Metadata
- Authors
- Lazarus, B. D., Love, D. C., & Hanover, J. A.
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 41
- Issue
- 11
- Pages
- 2134-2146
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W2009505041
- Cited by
- 99
- References
- 14
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.